JP5819865B2 - 小腸刷子縁膜ナトリウム/リン酸塩共−輸送のアリールフルオロホスフェート阻害剤 - Google Patents

小腸刷子縁膜ナトリウム/リン酸塩共−輸送のアリールフルオロホスフェート阻害剤 Download PDF

Info

Publication number
JP5819865B2
JP5819865B2 JP2012557128A JP2012557128A JP5819865B2 JP 5819865 B2 JP5819865 B2 JP 5819865B2 JP 2012557128 A JP2012557128 A JP 2012557128A JP 2012557128 A JP2012557128 A JP 2012557128A JP 5819865 B2 JP5819865 B2 JP 5819865B2
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
formula
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012557128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013521337A5 (https=
JP2013521337A (ja
Inventor
ピーアス ブライアン
ピーアス ブライアン
スロモウィッツ ラリー
スロモウィッツ ラリー
Original Assignee
デュオフォス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by デュオフォス filed Critical デュオフォス
Publication of JP2013521337A publication Critical patent/JP2013521337A/ja
Publication of JP2013521337A5 publication Critical patent/JP2013521337A5/ja
Application granted granted Critical
Publication of JP5819865B2 publication Critical patent/JP5819865B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/141Esters of phosphorous acids
    • C07F9/146Esters of phosphorous acids containing P-halide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/14Esters of phosphoric acids containing P(=O)-halide groups
    • C07F9/1406Esters of phosphoric acids containing P(=O)-halide groups containing the structure Hal-P(=O)-O-aryl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2012557128A 2010-03-05 2011-03-04 小腸刷子縁膜ナトリウム/リン酸塩共−輸送のアリールフルオロホスフェート阻害剤 Expired - Fee Related JP5819865B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31090210P 2010-03-05 2010-03-05
US61/310,902 2010-03-05
PCT/US2011/027232 WO2011109731A2 (en) 2010-03-05 2011-03-04 Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport

Publications (3)

Publication Number Publication Date
JP2013521337A JP2013521337A (ja) 2013-06-10
JP2013521337A5 JP2013521337A5 (https=) 2015-08-13
JP5819865B2 true JP5819865B2 (ja) 2015-11-24

Family

ID=44542860

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012557128A Expired - Fee Related JP5819865B2 (ja) 2010-03-05 2011-03-04 小腸刷子縁膜ナトリウム/リン酸塩共−輸送のアリールフルオロホスフェート阻害剤

Country Status (13)

Country Link
US (2) US8921343B2 (https=)
EP (1) EP2542560B8 (https=)
JP (1) JP5819865B2 (https=)
CN (1) CN102918050B (https=)
AU (1) AU2011222551B2 (https=)
BR (1) BR112012022349B1 (https=)
CA (1) CA2792093C (https=)
ES (1) ES2561672T3 (https=)
IL (1) IL221747A (https=)
MX (1) MX2012010288A (https=)
NZ (1) NZ602703A (https=)
RU (1) RU2566757C2 (https=)
WO (1) WO2011109731A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011222551B2 (en) * 2010-03-05 2016-10-06 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
WO2017111087A1 (ja) * 2015-12-25 2017-06-29 ステラケミファ株式会社 モノフルオロリン酸エステル塩、その製造方法及びフッ素イオン放出性組成物
CN119431437B (zh) * 2024-11-04 2025-09-30 山东花物堂生物科技有限公司 丹皮酚磷酸酯及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371910A1 (en) * 1999-01-21 2000-07-27 Brian E. Peerce Inhibitors of intestinal apical membrane na/phosphate co-transportation
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
ATE337326T1 (de) * 2002-03-19 2006-09-15 Genzyme Corp Hemmer des phosphattransports
RU2279676C2 (ru) * 2003-06-16 2006-07-10 Уральская государственная академия ветеринарной медицины Способ контроля над репаративным остеогенезом у животных
ES2633689T3 (es) * 2009-01-26 2017-09-22 Opko Ireland Global Holdings, Limited Regulación de fosfato con moléculas pequeñas
AU2011222551B2 (en) * 2010-03-05 2016-10-06 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport

Also Published As

Publication number Publication date
US20130059822A1 (en) 2013-03-07
EP2542560A4 (en) 2014-10-15
HK1180692A1 (zh) 2013-10-25
AU2011222551A1 (en) 2012-09-27
BR112012022349A2 (pt) 2016-07-05
EP2542560B8 (en) 2015-12-30
NZ602703A (en) 2015-01-30
WO2011109731A2 (en) 2011-09-09
US8921343B2 (en) 2014-12-30
MX2012010288A (es) 2013-02-27
AU2011222551B2 (en) 2016-10-06
BR112012022349B1 (pt) 2019-09-24
CA2792093C (en) 2018-05-22
US9328128B2 (en) 2016-05-03
US20150080597A1 (en) 2015-03-19
ES2561672T8 (es) 2016-03-11
RU2012142336A (ru) 2014-04-10
EP2542560A2 (en) 2013-01-09
CN102918050A (zh) 2013-02-06
CA2792093A1 (en) 2011-09-09
IL221747A (en) 2016-02-29
ES2561672T3 (es) 2016-02-29
JP2013521337A (ja) 2013-06-10
RU2566757C2 (ru) 2015-10-27
CN102918050B (zh) 2015-07-01
WO2011109731A3 (en) 2012-03-01
EP2542560B1 (en) 2015-11-11

Similar Documents

Publication Publication Date Title
IL211429A (en) HISTORY 1 - Naphthalene triazole and a pharmaceutical composition containing them
US12060379B2 (en) Plasmalogen derivatives
AU2012338362B2 (en) Tricyclic compounds, compositions comprising them and uses thereof
EA026300B1 (ru) Активаторы ampk и их применение в терапевтических целях
KR20150081365A (ko) 신규한 벤젠 설폰아미드 티아졸 화합물
JPH02202896A (ja) リン脂質ヌクレオシド類
CN112851647B (zh) 布雷菲德菌素a衍生物及其制备方法和用途
CN112851648B (zh) 布雷菲德菌素a酯类衍生物在抗肿瘤药物中的应用
JP2020002165A (ja) ジピコリルアミン誘導体及びそれらの薬学的使用
JP5819865B2 (ja) 小腸刷子縁膜ナトリウム/リン酸塩共−輸送のアリールフルオロホスフェート阻害剤
US20250011347A1 (en) Novel plasmalogen derivative
EP3978473B1 (en) Compound containing an indoleacetic acid core structure and use thereof
WO2025242063A1 (zh) 一种联二炔类化合物及其组合物和用途
US20210206713A1 (en) Compounds and methods for the treatment of neurodegenerative diseases
JP5747263B2 (ja) 神経細胞死抑制剤
JP2010520236A (ja) リソフィリンアナログとその使用法
HK1180692B (en) Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
CN116178350A (zh) 一种天然来源大环内酯衍生物及其制备方法和作为抗肿瘤药物的应用
WO2003087109A1 (en) Medicaments containing glycerophosphoinositol-4-phosphate derivatives
KR100249408B1 (ko) (s)-2,3-디하이드로폴리프레놀,(s)-2,3-디하이드로폴리프레닐모노포스-페이트,이들의제조방법및이들을포함한암의성장또는전이억제용약제
JPH04264092A (ja) シクロトリホスファゼンのn,oスピロ環状誘導体とその製法および用途
CN108864114A (zh) 选择性a2a受体拮抗剂
CN118994004A (zh) (+)-sclerotiorin衍生物在抗分枝杆菌药物的应用
US4191777A (en) Maleic acid halfamides having blood pressure raising activity
CN116768908A (zh) 一种含n多环化合物及其制备方法与用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140304

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140304

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150313

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150324

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20150622

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150901

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151001

R150 Certificate of patent or registration of utility model

Ref document number: 5819865

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees